scispace - formally typeset
G

Giacomo Zoppini

Researcher at University of Verona

Publications -  190
Citations -  13063

Giacomo Zoppini is an academic researcher from University of Verona. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 55, co-authored 182 publications receiving 11099 citations. Previous affiliations of Giacomo Zoppini include Integra Telecom & University of Southampton.

Papers
More filters
Journal ArticleDOI

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

TL;DR: Clinicians who manage patients with NAFLD should not focus only on liver disease but should also consider the increased risk of cardiovascular disease and undertake early, aggressive risk factor modification.
Journal ArticleDOI

Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients.

TL;DR: This study demonstrates for the first time a strong, graded association of RDW with hsCRP and ESR independent of numerous confounding factors, and might provide a rationale to introduce the easy, inexpensive RDW in algorithms for cardiovascular risk prediction.
Journal ArticleDOI

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.

TL;DR: The evidence of an early effect on mortality suggests that prevention, early diagnosis, and treatment should be improved in type 2 diabetic patients and the highest SMRs in the diabetic cohort were for diabetes and liver cirrhosis.
Journal ArticleDOI

Relations Between Carotid Artery Wall Thickness and Liver Histology in Subjects With Nonalcoholic Fatty Liver Disease

TL;DR: In this paper, the severity of liver histopathology among NAFLD patients is strongly associated with early carotid atherosclerosis, independent of classical risk factors, insulin resistance, and metabolic syndrome features.
Journal ArticleDOI

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

TL;DR: It is suggested that NAFLD is associated with an increased prevalence of CKD and proliferative/laser-treated retinopathy in type 2 diabetic individuals independently of numerous baseline confounding factors.